MERCK KGAA
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1668-01-01
- Employees
- 62.9K
- Market Cap
- $84.2B
- Website
- http://www.merckgroup.com/de
Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)
- Conditions
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Registration Number
- NCT03089658
- Locations
- 🇫🇷
Avelumab ATU Unit, Lyon, France
Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants
- First Posted Date
- 2017-01-20
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 20
- Registration Number
- NCT03026088
- Locations
- 🇨🇳
Fuwai Hospital Chinese Academy of Medical Sciences, Beijing, China
Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers
- First Posted Date
- 2017-01-16
- Last Posted Date
- 2022-08-24
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 24
- Registration Number
- NCT03021642
- Locations
- 🇩🇪
For Recruiting Locations outside US, please Contact Merck KGaA Communication Center, Darmstadt, Germany
Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 8
- Registration Number
- NCT03010423
- Locations
- 🇨🇳
Peking union medical college hospital, Beijing, China
MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2019-01-18
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 2
- Registration Number
- NCT02949908
- Locations
- 🇩🇪
Please Contact the Merck KGaA Communication Center, Darmstadt, Germany
Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)
- First Posted Date
- 2016-09-30
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 594
- Registration Number
- NCT02921035
- Locations
- 🇸🇦
Research site, Riyadh, Saudi Arabia
🇲🇦Research site 2, Rabat, Morocco
🇲🇦Research site 3, Rabat, Morocco
A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 3000
- Registration Number
- NCT02889380
- Locations
- 🇨🇳
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
🇨🇳Reproductive Hospital Affiliated to Shandong University, Shandong, China
🇨🇳Peking University Third Hospital, Peking, China
An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)
- Conditions
- Interventions
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 444
- Registration Number
- NCT02806232
- Locations
- 🇩🇪
Please Contact the Communication Center, Darmstadt, Germany
MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 114
- Registration Number
- NCT02699515
- Locations
- 🇯🇵
NHO Kyushu Cancer Center, Fukuoka, Japan
🇯🇵Saitama Cancer Center, Kitaadachi-gun, Japan
🇯🇵NHO Shikoku Cancer Center, Matsuyama, Japan
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
- Conditions
- Interventions
- First Posted Date
- 2015-11-18
- Last Posted Date
- 2018-06-28
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 1064
- Registration Number
- NCT02607293
- Locations
- 🇩🇪
Merck KGaA Communication Center, Darmstadt, Germany